E3 Ligase Ligand 2

E3 Ligase Ligand 2

CAT N°: 36664
Price:

From 45.00 38.25

E3 ligase ligand 2 is an active metabolite of thalidomide (Item No. 14610) and an intermediate in the synthesis of proteolysis-targeting chimeras (PROTACs) containing thalidomide, a ligand for the E3 ubiquitin ligase cereblon (CRBN), used in targeted protein degradation.{65337,65339} E3 ligase ligand 2 is formed from thalidomide via hydroxylation. It decreases the production of TNF-? induced by 12-O-tetradecanoylphorbol 13-acetate (TPA; Item No. 10008014) in THP-1 cells when used at a concentration of 30 µM.{65338} E3 ligase ligand 2 (333 µM) completely inhibits the proliferation of human umbilical vein endothelial cells (HUVECs). It inhibits VEGF- and FGF2-induced angiogenesis by 14% in a chicken chorioallantoic membrane (CAM) assay in utero when administered at a dose of 100 µg/embryo.{65337}

We also advise you